A ntigen-presenting cells play an integral role in initiating immune responses. Efficient uptake of Ag, migration, and sustained interaction by these APC with specific T cells is essential to drive the formation of effector CD8 ϩ and CD4 ϩ T cell populations. While as a minimum, T cells require only a brief period of stimulation (1) , slight alterations in the timing and consistency of Ag presentation may result in considerable differences in the overall response (2) . Following activation, CD8 ϩ T cells develop various cytotoxic pathways by which they control virus-infected cells. These include the Fas/Fas ligand pathways (3) and perforin-mediated exocytosis (4) . APC expressing the relevant MHC-peptide complexes present an obvious target for elimination by pre-existing or recently activated CTL. Whereas removal of the Ag stimulus would enable activated T cells to disengage and migrate to the site of infection, premature killing by such CTL may prevent the recruitment and activation of many naive T cells present in the draining lymph nodes (LN). 4 In particular, lower affinity CTL precursors, or T cells not present within the draining LN at the time of initial infection, may not be stimulated if the availability of specific APC is limited by the early action of effector T cells in the LN.
The survival and life span of professional APC in vivo during the course of an immune response is relatively poorly understood. A couple of recent reports have demonstrated that Ag presentation is prolonged after HSV and influenza virus infection (5, 6) . Although it is known that CTL can kill peptide-labeled dendritic cells (DC) in vivo (7) (8) (9) (10) , little is known about the mechanisms involved in regulating these interactions. Medema et al. (11) demonstrated the up-regulation of a specific granzyme B inhibitor by DC following maturation by CD4 ϩ T cells and maturation signals such as LPS and anti-CD40. This was shown to protect DC from CTL-mediated lysis in vitro.
In this study, we sought to examine the survival APC in vivo following infection with HSV. Ag presentation persists in the draining popliteal LN (PLN) in the presence of significant numbers of CTL (5) . By transferring CTL specific for the immunodominant epitope from HSV glycoprotein B (gB 498 -505 ), we show the in vivo elimination of exogenous resting peptide-labeled DC by specific CTL, while maturation of these DC with LPS or anti-CD40 Ab prolonged their survival. Furthermore, pre-existing CTL abrogated endogenous Ag presentation within the draining PLN after HSV infection. However, cotransfer of activated virus-specific CD4 ϩ T cells with the CTL prolonged Ag presentation in the PLN. Together these data suggest that signals that activate APC may be capable of preventing CTL-induced elimination of APC, thereby promoting prolonged Ag presentation in secondary lymphoid tissues.
Materials and Methods
Mice, viruses, and peptide C57BL/6, gBT-I.1 (gBT-I) (12), OT-I (13), and OT-II (14) mice were maintained in specific pathogen-free conditions in the Department of Microbiology and Immunology, University of Melbourne, animal house following institutional guidelines. The gBT-I transgenic mice express a V␣2/ V␤8.1 ϩ TCR from a CTL clone (HSV-2.3) (15) that recognizes the HSV-1 gB 498 -505 determinant complexed with H-2K b . The OT-I and OT-II mice express MHC class I-and II-restricted TCR (V␣2/V␤5.1 ϩ ) specific for the OVA peptides OVA 257-264 and OVA 323-339 , respectively. The peptides SS-IEFARL (gB 498 -505 ), SIINFEKL (OVA 257-264 ), and KISQAVHAA-HAEINEAG (OVA 323-339 ) were obtained from Auspep. The KOS strain of HSV-1 was propagated and titered using VERO cells grown in MEM plus 10% FCS. The rHSV-OVA strain expressing the OVA protein was made by homologous recombination with a packaging competent hybrid vector (ori-AAV/HSV) in the manner described (16) .
T cell and DC cultures
Activated transgenic T cells from gBT-I, OT-I, or OT-II mice were generated in vitro by coculturing transgenic splenocytes with irradiated (3000 rad) C57BL/6 splenocytes, pulsed with the relevant peptide at 1 g/ml (10 Ϫ6 M). The cells were cultured for 4 days in the presence of IL-2 (500 U/ml) in RPMI 1640 plus 10% FCS, and LPS (0.25 g/ml) was added to the OT-II cells for the final 2 days of culture. C57BL/6 spleen-derived DC were grown in vitro in our laboratory from spleen precursors in NIH 3T3 supernatant and GM-CSF, as described previously (17) .
Adoptive transfers, virus infections, and DC immunizations
In vitro activated T cells (10 6 cells) were harvested and transferred into C57BL/6 mice. Twenty-four hours after transfer, mice were infected in each hind footpad with 4 ϫ 10 5 PFU HSV-1 KOS or HSV-OVA in PBS. Before harvesting, DC cultures were treated with anti-CD40 Ab (FGK45) (18) at 50 g/ml for 48 h, or LPS at 10 g/ml for 24 h to mature the cells. On the day of transfer, DC were harvested (naive, LPS, or CD40 treated), and half the cells in each group were pulsed with gB 498 -505 peptide at 1 g/ml for 45 min, 37°C. All cells (6 groups) were then labeled with CFSE (Molecular Probes) by incubating with CFSE (2.5 M) at 37°C for 10 min. Viable cell counts were performed, and C57BL/6 mice were immunized in the footpad with 5 ϫ 10 6 DC per foot.
mAbs and flow cytometry
The activation phenotype of in vitro activated gBT-I, OT-I, or OT-II T cells was determined using anti-CD8 allophycocyanin (53-6.7), anti-CD4 PE (GK1. 
Ex vivo CTL assay
Ex vivo CTL lysis was assessed by a 4-h chromium release assay with 51 Cr (150 mCi)-labeled EL4 cells with or without gB 498 -505 peptide at 1 g/ml. EL4 are a C57BL/6-derived (H-2 b ) MHC class II Ϫ thymoma cell line and were maintained in DMEM supplemented with 10% FCS. Single-cell suspensions prepared from the PLN of mice, immunized with DC 5 days earlier, were assayed at E:T ratios of 100:1. Statistical analysis was performed using Student's t test (95% confidence).
In vivo CTL assay
In vivo CTL activity was determined, as described previously (19) . Briefly, target cells were prepared from C57BL/6 splenocytes pulsed with 1 g/ml gB 498 -505 peptide and labeled with a high concentration (2.5 M) of CFSE (CFSE high population), or incubated without peptide and labeled with a low concentration (0.25 M) of CFSE (CFSE low population). An equal number of cells from each population ( 10 7 ) was adoptively transferred into mice, which were sacrificed 4 h later. Cell suspensions were analyzed by FACS, and each population was distinguished by their different fluorescent intensities. Lysis was determined by loss of the peptide-pulsed CFSE high population from the PLN in relation to the peptide-negative CFSE low population.
APC assays
The ex vivo detection of APC was performed, as described previously, using the HSV-specific hybridoma HSV2.3.2E2 (19) . Briefly, PLN were removed from mice infected with HSV or HSV-OVA in the footpad 2 or 5 days previously and treated with a collagenase/DNase solution (1 mg/ml collagenase type II (Worthington Biochemical) and 0.1% grade II bovine pancreatic DNase I (Boehringer Mannheim) in DMEM plus 10% FCS) for 20 min, followed by the addition of 50 l of 0.1 M EDTA for a further 5 min. Two-fold serial dilutions of the cells were made in flat-bottom, 96-well plates starting at 10 6 cells/well. A total of 10 5 hybridoma cells was added to each well and cultured overnight. The 5-bromo-4-chloro-3-indolyl ␤-D-galactoside (X-Gal) assays were performed on the cultures to identify the responding hybridomas by first washing the wells with PBS and fixing the cells with 100 l of PBS containing 2% formaldehyde and 0.2% glutaraldehyde for 5 min at 4°C. After a further wash, 50 l of a solution containing 1 mg/ml X-Gal, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, and 2 mM MgCl 2 in PBS was added to each well. Cultures were examined microscopically for the presence of blue (LacZ ϩ ) cells after 8-to 12-h incubation at 37°C. Titrations of known numbers of gB-presenting APC were used as controls to ensure the number of LacZ ϩ cells accurately represented numbers of APC. Statistical analysis was performed using Student's t test (95% confidence).
Results

Ag presentation in a cytolytic environment
A number of reports have demonstrated that CTL can lyse APC in an Ag-specific manner following injection of in vitro derived professional APC (7-10). The adaptive immune response to cutaneous HSV infection has been shown to peak in the draining PLN 5 days after infection (20 -22) . Substantial numbers of armed CTL specific for the immunodominant epitope from HSV glycoprotein B (gB 498 -505 ) can be found in PLN at this time (23) . We wanted to address whether HSV gB-presenting APC arising from this infection survive within the PLN in the face of these effector CTL. To ascertain the level of presentation, we used a CD8 ϩ T cell hybridoma specific for gB 498 -505 that expresses ␤-galactosidase under the control of the IL-2 promoter (24) . LN cells from infected mice were cultured with the hybridoma cells overnight, which allows for sensitive detection of APC presenting the virus-derived Ag (19, 25) . We have shown previously that this presentation is confined to the CD8␣ ϩ CD11C ϩ DC population within these tissues (26) . In this manner, we determined that a significant number of APCpresenting gB 498 -505 are detectable in the PLN of normal C57BL/6 mice 5 days after cutaneous infection with HSV (Fig.  1A) . Moreover, analysis of in vivo CTL activity within the PLN at this time demonstrated maximal killing of the CFSE-labeled targets (Fig. 1B) (23) . Thus, during the normal course of the immune response, many APC-presenting specific MHC class I-peptide ligands are capable of surviving within an environment that contains abundant cytolytic activity. Splenocytes from syngeneic mice were prepared and transferred into naive mice (0), or those infected 5 days previously (5) . gB-peptide-pulsed splenocytes were labeled with a high concentration of CFSE (CFSE high ), while unpulsed control targets were labeled with a low concentration of CFSE (CFSE low ). Four hours after target-cell transfer, mice were sacrificed and PLN cells were analyzed for relative elimination of the CFSE high vs CFSE low populations. Error bars represent SD.
In vivo abrogation of Ag presentation by CTL
We next examined whether endogenous APC possess a constitutive ability to survive interactions with armed CTL effectors. We have shown previously that significant gB 498 -505 presentation is detectable in the PLN 48 h after infection with HSV (5, 19) . However, few armed effectors are present at this early stage (23) . As a consequence, we could examine what effect introduced CTL populations had on this endogenous presentation in the absence of significant endogenous T cell responses. Infection of control C57BL/6 mice showed greater numbers of gB-presenting APC were present in the PLN at this time (Fig. 2) . To examine whether the presence of pre-existing CTL could eliminate such presentation, we adoptively transferred activated gBT-I CTL into mice before infection. These CTL were generated from CD8 ϩ T cells specific for gB 498 -505 derived from H-2K b -restricted TCR transgenic gBT-I mice (12) . The gBT-I CTL, activated in vitro with peptide in the presence of IL-2, displayed a typical activated phenotype (CD25 high , CD44 high , CD43 high , and CD62L low ), bound H-2K b -gB tetramers, and demonstrated excellent CTL activity both in vitro and in vivo (data not shown). Following transfer, we observed a significant reduction in detectable Ag presentation in the PLN in comparison with control mice (Fig. 2) . No detectable difference in viral clearance was observed in the tissues at this time (data not shown), suggesting that reduced Ag presentation in the PLN was not due to a reduction in virus in the tissues. Thus, the presence of pre-existing CTL dramatically reduced the number of endogenous gB-presenting APC in the draining LN following HSV infection, suggesting that these cells are not intrinsically resistant to CTL-mediated elimination.
Maturation of APC protects against CTL-mediated elimination
To enable the direct observation of APC elimination in vivo, we made use of DC lines, generated from splenic precursors cultured with GM-CSF (17) . The DC were either pulsed with gB 498 -505 peptide or left untreated, and all were labeled with CFSE before injecting mice in the footpad with 1 ϫ 10 6 cells per mouse. gBT-I CTL, or control OT-I CTL, were adoptively transferred into the mice, and 2 days later the draining PLN were removed and cell suspensions were analyzed by flow cytometry for the presence of CFSE ϩ DC. We could readily detect the CFSE-labeled DC in the draining LN of C57BL/6 mice, regardless of whether they had been pulsed with peptide before immunization (Fig. 3A) . This is in agreement with the migration patterns of DC following immunization described by others (7, 8, 27) . Most importantly, we found that gBT-I CTL abolished the appearance of resting DC within the PLN, while these same peptide-labeled DC survived in the presence of activated OT-I T cells (Fig. 3A) .
We next wanted to establish the effect of maturation signals on the survival of APC in vivo. DC were matured in vitro using either LPS or anti-CD40 Abs. The cultures contained Ͼ99% CD11c ϩ cells and displayed up-regulation of CD86 and MHC class II (I-A b ) molecules, in comparison with untreated (resting) cells, upon maturation with either stimulus. Notably, slightly higher expression of these markers was apparent after anti-CD40 treatment in comparison with LPS maturation. When the total number of DC in the PLN was determined 48 h after injection, it was clear that FIGURE 2. Effector CTL abrogate Ag presentation in the draining LN. The PLN from mice with (ϩ) or without (Ϫ) adoptively transferred gBT-I CTL were removed from naive mice or 2 days after HSV infection. Cells from individual PLN were incubated with gB-specific LacZ-inducible hybridoma cells, as described in Fig. 1 . Numbers represent the total number of APC per separate PLN. The mean of each data set is shown (Ϫ). ‫,ء‬ p Ͻ 0.0001. neither peptide-labeling nor maturation affected the migration or survival of the DC in vivo, with approximately equal numbers of cells isolatable in each case (Fig. 3B) . Moreover, both LPS-and CD40-matured DC were present in the PLN in mice with gBT-I CTL, indicating that the maturation of these APC protected them against CTL-induced lysis.
We next examined the immune response generated by immunization with peptide-pulsed DC, directly ex vivo using a standard 4-h 51 Cr assay. At the numbers transferred in this study, the gBT-I CTL showed minimal direct ex vivo killing because of low numbers present within the PLN (1-2% of CD8 ϩ T cells). Both resting and LPS-matured gB-presenting DC elicited comparable cytolytic activity in the PLN 5 days after immunization (Fig. 4) . The response was noticeably stronger following immunization with CD40-matured DC, supporting the role for CD40 and T cell help in promoting immune responses (28, 29) . Cotransfer of gBT-I CTL with resting peptide-labeled DC generated minimal CTL activity, correlating with elimination of the CFSE ϩ DC (Fig. 3) . No such abrogation was observed in control mice that received OT-I CTL. Together these data demonstrate that APC survival and functional priming in vivo in the presence of specific CTL are enhanced upon maturation of the DC.
CD4 ϩ T cells rescue APC from CTL
The above results suggested that the gB-specific CD8 ϩ T cells might exert their effects by killing gB-presenting APC, if such CTL were present at the early stages of the response. This raises the question of how such APC can survive in the presence of endogenous CTL generated during the normal progression of the response (see Fig. 1 ). Medema et al. (11) used an in vitro model to demonstrate that helper-derived signals can mature DC, inducing the expression of a granzyme B inhibitor that protects against CTL-induced lysis. This suggested that following in vivo infection, APC may initiate protective measures to survive interactions with CTL. To examine the role of Ag-specific CD4 ϩ T cell help, we made use of a recombinant strain of HSV expressing the OVA protein (HSV-OVA). Effector CD4 ϩ T cells were produced by in vitro peptide stimulation of OT-II transgenic T cells specific for the I-A b -restricted OVA 323-339 peptide. The effector OT-II CD4 ϩ T cells proliferated extensively; up-regulated CD25, CD44, and CD43; and down-regulated CD62L (data not shown). Mice were adoptively transferred with combinations of effector gBT-I and OT-II T cells either alone or together, before infection with HSV-OVA or wild-type HSV via the footpad. Two days later, gB-presenting APC from the PLN were quantitated using the LacZ-inducible T cell hybridomas. An equivalent level of gB presentation was detected after HSV or HSV-OVA infection of mice transferred with OT-II cells alone or no cells (B6) (Fig. 5) . The ability of gBT-I CTL to abolish gB 498 -505 presentation was established after both HSV and HSV-OVA infection. Following the cotransfer of gBT-I and OT-II cells, we were able to detect significant numbers of gB-presenting APC in the PLN after infection with HSV-OVA, but not HSV. This suggested that the CD4 ϩ T cells were prolonging Ag presentation within the PLN in an Ag-specific manner. Together these results suggest that APC involved in the initiation of viral immunity can resist CTL-mediated attack as a consequence of signals derived from interactions with Th cells.
Discussion
The nature of APC in acquiring Ag and initiating immune responses has been the focus of considerable research over the past decade. Although we know significantly more about APC and the signals required to activate T cells, there has been little focus on FIGURE 4. Eradication of DC by CTL abrogates priming of gB-specific T cells. Mice were immunized with resting (untreated), LPS-, or CD40-matured DC, with or without gB peptide, and cotransferred with gBT-I, OT-I, or no cells (none), as described in Fig. 3 . After 5 days, the PLN were removed and assayed in a 4-h 51 Cr assay using peptide-labeled EL4 targets. An E:T ratio of 100:1 is shown. Error bars represent SD. ‫,ءء‬ p ϭ 0.0001.
FIGURE 5. CD4
ϩ T cells rescue Ag presentation in the draining LN. Mice were adoptively transferred with activated OT-II, gBT-I, OT-II, and gBT-I, or no cells (none) before cutaneous infection with either HSV or a recombinant virus expressing OVA (HSV-OVA). A cohort of mice in each group was also left uninfected (naive). Two days after HSV infection, cells from individual PLN were incubated with gB-specific LacZ-inducible hybridoma cells, as described in Fig. 1 . The mean of each data set is shown (Ϫ). ‫,ء‬ p Ͻ 0.001. the fate of the APC after these interactions. Efficient contact between CD8
ϩ T cells and APC drives the formation of highly active CTL. Yet, once activated, what prevents the CTL from destroying the APC?
Detectable Ag presentation persists for at least 7 days following HSV infection (5) , despite the presence of maximal CTL numbers in the PLN at this time (23) . Given the relatively short t 1/2 of MHC class I complexes on cell surfaces (30) , this suggests that following cutaneous HSV infection, a steady influx of APC from the tissues may provide a continuous Ag source in the PLN. Nevertheless, removal of the site of infection, and thus this putative flow of Ag, 8 h after infection demonstrates that specific APC may survive for up to 4 days in vivo (5) . Infections such as Sendai virus and influenza virus can involve presentation in the draining LN for 10 days to 4 wk, respectively, presumably in the presence of considerable numbers of CTL (6, 25) . We show in this study that DC lysis resulted in the abrogation of CTL priming in the PLN, suggesting that, during HSV infection, APC are at least partially protected from such destruction.
We examined the role of CD4 ϩ and CD8 ϩ T cells in the survival of introduced APC in vivo and the effect this has on the resulting immune response. The benefits of sustained T cell-APC interactions in effector and memory generation suggest that APC ought to have a means of protecting themselves from CTL. It is known that DC are resistant to killing via Fas (CD95) (31) , yet killing of APC can occur independent of either perforin or Fas (9) . Evidence that maturation of DC results in up-regulation of the granzyme B inhibitor SPI-6 (11) suggests that APC are capable of surviving interactions with effector CD8 ϩ T cells, at least in vitro. Evidence also suggests that DC are programmed to die, but T cell help may prolong their survival (32) . We show in this study that Ag-specific CD4 ϩ T cells can protect endogenous APC from CTLmediated elimination during the course of a viral infection. This may constitute an important mechanism involved in the regulation of immune responses. Yet, the exact means by which Th cells protect are uncertain. Although it is likely that CD40L (CD154) is involved, other molecules such as Fas ligand, which, like CD40L, is up-regulated on the surface of effector CD4 ϩ T cells (33, 34) , have been shown to induce the maturation of DC (35) . In support of this, we demonstrate that maturation signals alone, such as anti-CD40 stimulation or bacterial LPS, are sufficient to protect DC from elimination by CTL.
We show that CTL can remove both endogenous and introduced APC presenting the gB 498 -505 peptide, if they are present sufficiently early during the immune response. This supports previous reports showing that killing of DC can occur in vivo (7) (8) (9) (10) . The loss of peptide-pulsed DC correlated with a lack of CTL priming within the PLN, suggesting that the gBT-I CTL were killing APC either in the PLN or within the tissues themselves. A recent report by Ronchese and colleagues (36) suggested that DC killing occurs within the tissues, not the LN, because DC were not killed if present in the LN before the transfer of CTL. We cannot rule out that gBT-I CTL simply held the gB-presenting APC in the tissues or prevented their entry into the PLN. We feel this is unlikely, however, given that LPS-and CD40-matured DC were able to migrate into the PLN, despite the presence of the gBT-I CTL.
In the course of a normal immune response, both CD4 ϩ and CD8 ϩ T cells are activated in concert, thus allowing helper-APC interactions to occur before expression of lytic capability by CD8 ϩ T cells. Protecting the life span of an APC, however briefly, may have important consequences to immunity if a greater number of naive cells can be activated. Clearly, some level of APC killing would be expected to occur, particularly as the number of maturing CTL reaches a critical threshold. This may serve to limit the duration of Ag presentation, as has been suggested for Listeria monocytogenes infection (37), although differences in the pathogen or the magnitude of the helper response may define the extent of presentation. Nonetheless, it is likely that there exists a balance between APC survival and death based on the degree of interaction between CD4 ϩ and CD8 ϩ T cells. In addition, the phenomenon of APC killing may have more of a role in secondary responses, whereby rapid responses by pre-existing CTL can inhibit other similar or cross-reactive specificities (38 -40) .
In summary, we demonstrate that endogenous APC-presenting viral peptides following HSV infection can be killed in an Agspecific manner by pre-existing CTL in vivo. Addition of CD4 ϩ T cells can prolong the survival of gB-presenting APC following HSV infection. In addition, maturation of DC via LPS or anti-CD40 protected against CTL lysis in vivo, promoting the priming of an anti-gB response, whereas CTL-induced loss of the resting DC suppressed this immunity. This may have important implications for our understanding of the control of immune responses, in particular the significance of CD4 ϩ T cell-derived help in both promoting and optimizing immune responses to viral infection.
